[go: up one dir, main page]

WO2005124563A9 - Compounds and kits for treating muscle disorders and methods of use thereof - Google Patents

Compounds and kits for treating muscle disorders and methods of use thereof Download PDF

Info

Publication number
WO2005124563A9
WO2005124563A9 PCT/US2005/020903 US2005020903W WO2005124563A9 WO 2005124563 A9 WO2005124563 A9 WO 2005124563A9 US 2005020903 W US2005020903 W US 2005020903W WO 2005124563 A9 WO2005124563 A9 WO 2005124563A9
Authority
WO
WIPO (PCT)
Prior art keywords
kits
compounds
methods
muscle disorders
treating muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/020903
Other languages
French (fr)
Other versions
WO2005124563A3 (en
WO2005124563A2 (en
Inventor
Alfred Stracher
Leo Kesner
Norman W. Barton
Theodore E. Carver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CEPTOR Corp
Original Assignee
CEPTOR Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CEPTOR Corp filed Critical CEPTOR Corp
Priority to US11/321,782 priority Critical patent/US20080039531A1/en
Publication of WO2005124563A2 publication Critical patent/WO2005124563A2/en
Anticipated expiration legal-status Critical
Publication of WO2005124563A3 publication Critical patent/WO2005124563A3/en
Publication of WO2005124563A9 publication Critical patent/WO2005124563A9/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Described herein are compounds and kits for treating muscle disorders and methods of use thereof.
PCT/US2005/020903 2004-06-12 2005-06-13 Compounds and kits for treating muscle disorders and methods of use thereof Ceased WO2005124563A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/321,782 US20080039531A1 (en) 2005-06-13 2005-12-28 Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57891404P 2004-06-12 2004-06-12
US60/578,914 2004-06-12
US63327404P 2004-12-03 2004-12-03
US60/633,274 2004-12-03

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/321,782 Continuation-In-Part US20080039531A1 (en) 2005-06-13 2005-12-28 Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders

Publications (3)

Publication Number Publication Date
WO2005124563A2 WO2005124563A2 (en) 2005-12-29
WO2005124563A3 WO2005124563A3 (en) 2008-10-02
WO2005124563A9 true WO2005124563A9 (en) 2011-09-15

Family

ID=35510387

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/020903 Ceased WO2005124563A2 (en) 2004-06-12 2005-06-13 Compounds and kits for treating muscle disorders and methods of use thereof

Country Status (1)

Country Link
WO (1) WO2005124563A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1993591A4 (en) * 2006-02-28 2009-08-19 Univ New York State Res Found TARGETED DELIVERY OF PHARMACEUTICAL COMPOUNDS
CN101631568B (en) 2007-03-12 2012-08-22 尼克塔治疗公司 Oligomer-protease inhibitor conjugates
GB0715087D0 (en) 2007-08-03 2007-09-12 Summit Corp Plc Drug combinations for the treatment of duchenne muscular dystrophy
PL2170396T3 (en) 2007-08-03 2017-07-31 Summit (Oxford) Limited Drug combinations for the treatment of duchenne muscular dystrophy
WO2009114151A1 (en) 2008-03-12 2009-09-17 Nektar Therapeutics Oligomer-amino acid and olgomer-atazanavir conjugates
CN104069117A (en) * 2014-07-03 2014-10-01 滨州医学院 Application of amprenavir in preparation of medicine for preventing or treating ischemic cardiovascular and cerebrovascular diseases
WO2022155656A1 (en) 2021-01-13 2022-07-21 Rodan & Fields, Llc Cosmetic compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866040A (en) * 1986-01-06 1989-09-12 Alfred Stracher Aminocarnitine directed pharmaceutical agents

Also Published As

Publication number Publication date
WO2005124563A3 (en) 2008-10-02
WO2005124563A2 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
WO2006071960A3 (en) Compositions and methods of treating cell proliferation disorders
WO2005030144A3 (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
WO2003082208A3 (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
IL233634A0 (en) Methods, compositions, and kits for the treatment of medical conditions
WO2006023651A3 (en) Extended treatment of multiple sclerosis
WO2006003388A8 (en) Compositions and methods for treating inflammatory disorders
WO2006078287A3 (en) Pde4b inhibitors and uses therefor
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
IL182837A0 (en) Methods, assays and compositions for treating retinol-related diseases
WO2006121421A8 (en) Methods and formulations for treating glaucoma
WO2006055871A3 (en) Treatment for multiple sclerosis
WO2004084943A8 (en) Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
WO2005000208A3 (en) Combination therapy for the treatment of neoplasms
WO2005124563A3 (en) Compounds and kits for treating muscle disorders and methods of use thereof
WO2004105696A3 (en) Combination therapy for the treatment of neoplasms
WO2006036394A3 (en) Methods for making retinoids and uses thereof
WO2004100873A3 (en) Compounds, compositions, and methods
WO2006109301A3 (en) Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
WO2006135694A3 (en) Uii-modulating compounds and their use
WO2005077018A3 (en) Methods of treating skin disorders
EP1755637B8 (en) Methods for preventing or treating bone disorders
WO2005110391A3 (en) Compounds for treating human papillomavirus
WO2006012222A3 (en) Methods of treating smooth muscle cell disorders
WO2004091547A3 (en) Compounds, compositions, and methods
WO2006066110A3 (en) Cav2 RELATED COMPOSITIONS AND METHODS

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 11321782

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05760647

Country of ref document: EP

Kind code of ref document: A2